[New] West Pharmaceutical warned in the United States that a ransomware attack was affecting operations at a company supplying containment and delivery systems to healthcare and pharmaceutical customers.
Digital Forensics Magazine
[New] The pharmaceutical companies segment held a 18% share in 2025 and is expected to register a significant growth of 25.5% CAGR during 2026 and 2035, owing to the growing complexity of drug development processes and pharmacovigilance workflows.
Precedence Research
[New] By tying U.S. drug prices to international prices, prospective MFN will lower U.S. prices and put upward pressure on prices paid in other wealthy nations.
The White House
[New] The ongoing litigation risk surrounding MFN policies - particularly related to the Global Benchmark for Efficient Drug Pricing (GLOBE) and Guarding U.S. Medicare Against Rising Drug Costs (GUARD) models - further elevates their profile as a likely target for congressional oversight.
JD Supra
[New] IQVIA will integrate its AI-enabled clinical trial capabilities in a biosimilar development and commercialization collaboration with Kexing Biopharm.
Contract Pharma
[New] By 2026, more pharmaceutical manufacturing plants will deploy connected digital platforms spanning discovery, development, scale-up, manufacturing, and supply chain.
International Multispeciality Journal of Health
[New] Well over a million people die each year from drug-resistant bacteria, and by 2050, the World Health Organization estimates that number could be 10 times higher.
New York Post
[New] Looming tariffs, reportedly up to 200%, on U.S. pharmaceutical imports could drive up costs and affect international trade dynamics.
BUSINESS 2.0 NEWS
Novo Nordisk is raising its forecast for 2026 as the weight-loss drug Wegovy is selling better than expected, helped by a pill version launched in January.
Sweden Herald
The pharmaceutical group said it now expects adjusted sales and operating profit for 2026 to decline between 4% and 12% at constant exchange rates, representing a narrower contraction than previously anticipated and reflecting stronger expectations for its GLP-1 treatment portfolio.
Yahoo Finance
President Donald Trump's deals with pharmaceutical companies to drop some of their U.S. prescription drug prices to what they charge in other countries could save $529 billion over the next decade.
MM+M - Medical Marketing and Media
FDA discussion spikes unusually, likely tied to drug shortages from Iranian supply disruptions that hit pharmaceutical imports.
TheEye
The Ozempic oral pill, approved by the Food and Drug Administration (FDA), offers an option for adults with type 2 diabetes to manage blood sugar and cardiovascular risk alongside diet and exercise.
Pharmaceutical Technology
Mr Trump's most favoured nation drug policy, which aims to lower US prescription drug costs by pegging them to the lowest prices in other developed nations, could still lead to pricing pressures in the near term.
ST
A single validated liver-chip workflow could save the pharmaceutical industry $3 billion by replacing a single toxicity test.
Yahoo News UK
In 2026, overall drug spending will exceed $1 trillion for the first time - a milestone driven primarily by more patients using more medications, not because of rising prices.
Cision PR Newswire
Last updated: 26 May 2026
Hi,
Would you like a quick online demo of our service from an experienced member of our team?
